New rules on inversion mergers announced yesterday by the U.S. Treasury Dept. send shares of Medtronic and Covidien down as questions swirl about the impact ion their pending $43 billion merger.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1ogcNZ4
Cap comentari:
Publica un comentari a l'entrada